iScience Interventional

About:

iScience Interventional provides microcatheter and imaging technologies for ophthalmologists to deliver site-specific ocular therapies.

Website: http://www.iscienceinterventional.com

Top Investors: Asset Management Ventures (AMV), Prism Venture Management, DeNovo Ventures, Three Arch Partners, Johnson & Johnson Development Corporation

Description:

iScience Interventionalâ„¢ discovers and develops microcatheter and imaging technologies that enable ophthalmologists to deliver site-specific ocular therapies. This new category of therapy is called Interventional Ophthalmology. It encompasses microcatheter-based therapies designed to access a wide range of anatomical structures within the eye to aspirate ocular fluids or deliver sterile ophthalmic solutions to the eye.

Total Funding Amount:

$83.7M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Menlo Park, California, United States

Founded Date:

1999-01-01

Contact Email:

info(AT)iscienceinterventional.com

Founders:

Michael Nash, Stan Conston

Number of Employees:

51-100

Last Funding Date:

2012-05-08

IPO Status:

Private

Industries:

© 2025 bioDAO.ai